About ProBion Wasa Medicals:
ProBion is based on science and demonstrated evidence and they follow rigorous scientific process. ProBion tablet disintegration profile has been verified according to the European Pharmacopoeia. This provides common quality standards throughout the pharmaceutical industry in Europe to control the quality of medicines, and the substances used to manufacture them.
The Invention behind ProBion is responsible for the remarkable success of ProBion probiotic used as the preferred regimen during recent colon cancer clinical trial published in the BMJ (formerly British Medical Journal) of Open Gastroenterology July 2017. The final outcome showed that 2 x tables of ProBion Clinica a day for an average of 31 days (range: 8 to 78 days) had altered a significant amount of cancer-associated harmful bacteria and generated a plethora of beneficial bacteria with anti-inflammatory effects.
They will perform both clinical and basic science studies looking upon the effects of probiotics on various diseases, such as colon cancer, metabolic diseases, celiac disease, infertility and irritable bowel syndrome. They collaborate with universities, hospitals and institutions around the world. They believe that their research at Wasa Medicals will greatly enhance the health and quality of life for people.
Contact:
Address: Schélevägen 1 SE-302 91 Halmstad Sweden
Phone: 850638607
Emails: [email protected]
